227 related articles for article (PubMed ID: 27553858)
1. Serum pentraxin 3 is elevated in patients with neurological Wilson's disease.
Wang H; Cheng N; Dong J; Wang X; Han Y; Yang R; Han Y
Clin Chim Acta; 2016 Nov; 462():178-182. PubMed ID: 27553858
[TBL] [Abstract][Full Text] [Related]
2. Comparative assessment of clinical rating scales in Wilson's disease.
Volpert HM; Pfeiffenberger J; Gröner JB; Stremmel W; Gotthardt DN; Schäfer M; Weiss KH; Weiler M
BMC Neurol; 2017 Jul; 17(1):140. PubMed ID: 28732478
[TBL] [Abstract][Full Text] [Related]
3. Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia.
Kao SJ; Yang HW; Tsao SM; Cheng CW; Bien MY; Yu MC; Bai KJ; Yang SF; Chien MH
Clin Chem Lab Med; 2013 Apr; 51(4):907-13. PubMed ID: 23152412
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum brain natriuretic peptide and matrix metalloproteinases 2 and 9 in Wilson's disease.
Cheng N; Wang H; Dong J; Pan S; Wang X; Han Y; Han Y; Yang R
Metab Brain Dis; 2015 Aug; 30(4):1087-91. PubMed ID: 26077744
[TBL] [Abstract][Full Text] [Related]
5. Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.
Soeki T; Niki T; Kusunose K; Bando S; Hirata Y; Tomita N; Yamaguchi K; Koshiba K; Yagi S; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Akaike M; Sata M
J Cardiol; 2011 Sep; 58(2):151-7. PubMed ID: 21676590
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokines expression in Wilson's disease.
Wu P; Dong J; Cheng N; Yang R; Han Y; Han Y
Neurol Sci; 2019 May; 40(5):1059-1066. PubMed ID: 30644005
[TBL] [Abstract][Full Text] [Related]
7. Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease.
Chang CC; Wang PH; Su PH; Lin DB; Ying TH; Yang SF; Hsieh YH
Clin Chem Lab Med; 2011 Oct; 49(10):1655-60. PubMed ID: 21679133
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X
Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252
[TBL] [Abstract][Full Text] [Related]
9. Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
Xu Y; Ding X; Zou J; Liu Z; Jiang S; Xu S; Shen B; Chen Y; Shan Y; Cao X
Ren Fail; 2011; 33(10):998-1004. PubMed ID: 22013933
[TBL] [Abstract][Full Text] [Related]
10. Levels of pentraxin-3 in gingival crevicular fluid and plasma in periodontal health and disease.
Pradeep AR; Kathariya R; Raghavendra NM; Sharma A
J Periodontol; 2011 May; 82(5):734-41. PubMed ID: 21080790
[TBL] [Abstract][Full Text] [Related]
11. Estimation of pentraxin-3 levels in the gingival tissues of chronic and aggressive periodontitis participants: an in vivo study.
Lakshmanan R; Jayakumar ND; Sankari M; Padmalatha O; Varghese S
J Periodontol; 2014 Feb; 85(2):290-7. PubMed ID: 23701480
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin 3 and C-reactive protein in severe meningococcal disease.
Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M
Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775
[TBL] [Abstract][Full Text] [Related]
13. A novel Global Assessment Scale for Wilson's Disease (GAS for WD).
Aggarwal A; Aggarwal N; Nagral A; Jankharia G; Bhatt M
Mov Disord; 2009 Mar; 24(4):509-18. PubMed ID: 19115420
[TBL] [Abstract][Full Text] [Related]
14. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
15. Renal impairment in different phenotypes of Wilson disease.
Wang H; Zhou Z; Hu J; Han Y; Wang X; Cheng N; Wu Y; Yang R
Neurol Sci; 2015 Nov; 36(11):2111-5. PubMed ID: 26219584
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of neurological Wilson's disease with corpus callosum abnormalities.
Zhou ZH; Wu YF; Cao J; Hu JY; Han YZ; Hong MF; Wang GQ; Liu SH; Wang XM
BMC Neurol; 2019 May; 19(1):85. PubMed ID: 31053106
[TBL] [Abstract][Full Text] [Related]
17. Wilson's disease: monocentric experiences over a period of 10 years [corrected].
Prochazkova D; Pouchla S; Mejzlik V; Konecna P; Michalek J; Bartosova D; Hrstkova H
Klin Padiatr; 2009 Dec; 221(7):419-24. PubMed ID: 20013564
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of pentraxin 3 in patients with spondyloarthritis.
Nisihara R; Skare TL; Zeni JO; Rasera H; Lidani K; Messias-Reason I
Biomarkers; 2018 Feb; 23(1):14-17. PubMed ID: 28043168
[TBL] [Abstract][Full Text] [Related]
19. The role of pentraxin-3 as a prognostic biomarker in paraquat poisoning.
Yeo CD; Kim JW; Kim YO; Yoon SA; Kim KH; Kim YS
Toxicol Lett; 2012 Jul; 212(2):157-60. PubMed ID: 22210019
[TBL] [Abstract][Full Text] [Related]
20. [Values of serum copper and serum free copper in the diagnosis and monitoring of Wilson's disease and its carriers].
Zhou XX; Li XH; Huang HW; Liu B; Zhu RL; Liang YY; Zhu JZ; Liang XL
Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(39):2757-60. PubMed ID: 22322054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
